Articles

Cell-based immunotherapy shows promise against melanoma

Source: SITEMAN Cancer Center, Julia Evangelou Strait, June 2021.

Wugen: deploying memory NK cells against cancer

Source: BIOCENTURY Wugen: deploying memory NK cells against cancer AND TURNING ALLOGENEIC CAR T CELLS AGAINST T CELL MALIGNANCIES BY LAUREN MARTZ, …

The Development of Natural Killer Cells for Solid Tumor Treatment

Currently approved cellular therapies have been shown to effectively treat B-cell cancers, but there remains a significant unmet need for treating other cancers, including solid tumors.

BioWorld: Alpha Biopharma lands deal for Wugen’s memory NK and CAR T cells for Asia

BioWorld, David Ho, March 2021.

The Promise of Natural Killer Cells

Technology Networks, Ryan Sullivan, Wugen, March 2021

St. Louis biotech startup Wugen inks manufacturing deal, hires C-suite exec

St. Louis Business Journal, Nathan Rubbelke, March 2021

St. Louis biotech startup Wugen inks licensing deal, hires new C-suite exec

St. Louis Business Journal, Nathan Rubbelke, February 2021

Wugen Ramps Up Off-the-Shelf Gene Therapies to Fight Cancer

Biospace, Kate Goodwin, January 2021

Latest News

Wugen Raises $172 Million to Advance Clinical Stage Memory NK Cell Platform, Progress Best-In-Class AML Program, and Initiate Multiple Solid Tumor Trials

Proceeds to advance clinical development of WU-NK-101 for relapsed/refractory AML, and initiate studies in solid …

A fusion protein complex that combines IL12, IL15, and IL18 signaling to induce memory-like NK cells for cancer immunotherapy

Cancer Immunol Res, Becker-Hapak et al., July 2021

Cell-based immunotherapy shows promise against melanoma

Source: SITEMAN Cancer Center, Julia Evangelou Strait, June 2021.

Next in our story

Career Opportunities

ST. LOUIS

4340 Duncan Ave
Suite 302
St. Louis, MO 63110

SAN DIEGO

9880 Campus Point Dr
Suite 420
San Diego, CA 92121

SOCIAL

a COGNEO design